We are live on ! Find out more
ETC

Exchange Traded Concepts Portfolio holdings

AUM $21.9B
1-Year Est. Return 68.6%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
AUM
$5.16B
AUM Growth
+$1.25B
Cap. Flow
+$1.15B
Cap. Flow %
22.29%
Top 10 Hldgs %
42.34%
Holding
1,276
New
184
Increased
652
Reduced
277
Closed
104

Sector Composition

Rank Sector Weight
1 Technology 13.31%
2 Healthcare 6.99%
3 Communication Services 6.95%
4 Consumer Discretionary 6.11%
5 Energy 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GH icon
201
Guardant Health
GH
$19.3B
$2.9M 0.06%
+29,017
New +$3M
CDNA icon
202
CareDx
CDNA
$1.88B
$2.89M 0.06%
63,451
+18,662
+42% +$974K
MRNA icon
203
Moderna
MRNA
$22.1B
$2.88M 0.06%
11,328
+936
+9% +$274K
REGN icon
204
Regeneron Pharmaceuticals
REGN
$69.9B
$2.87M 0.06%
4,545
-547
-11% -$336K
GOOD
205
Gladstone Commercial Corp
GOOD
$627M
$2.87M 0.06%
111,283
-2,387
-2% -$54.2K
MEDP icon
206
Medpace
MEDP
$16.5B
$2.85M 0.06%
13,105
-1,612
-11% -$338K
CLLS
207
Cellectis
CLLS
$291M
$2.82M 0.05%
347,174
+111,591
+47% +$1.1M
ALGN icon
208
Align Technology
ALGN
$12B
$2.81M 0.05%
4,276
-274
-6% -$176K
AXGN icon
209
Axogen
AXGN
$2.19B
$2.8M 0.05%
299,238
+92,543
+45% +$1.11M
HCAT icon
210
Health Catalyst
HCAT
$159M
$2.74M 0.05%
69,127
+7,089
+11% +$323K
QDEL icon
211
QuidelOrtho
QDEL
$1.15B
$2.72M 0.05%
20,147
-4,911
-20% -$684K
NTST
212
NETSTREIT Corp
NTST
$2.13B
$2.71M 0.05%
118,320
-5,254
-4% -$122K
EXAS
213
DELISTED
Exact Sciences
EXAS
$2.67M 0.05%
34,362
+3,772
+12% +$333K
MELI icon
214
Mercado Libre
MELI
$92.3B
$2.67M 0.05%
1,980
+1,038
+110% +$1.46M
VRTX icon
215
Vertex Pharmaceuticals
VRTX
$122B
$2.66M 0.05%
12,110
-3,346
-22% -$651K
SYK icon
216
Stryker
SYK
$129B
$2.64M 0.05%
9,888
-390
-4% -$102K
BMY icon
217
Bristol-Myers Squibb
BMY
$128B
$2.63M 0.05%
42,261
-217,899
-84% -$12.8M
NVCR icon
218
NovoCure
NVCR
$1.97B
$2.62M 0.05%
34,861
+20,985
+151% +$2.11M
RVTY icon
219
Revvity
RVTY
$12.1B
$2.59M 0.05%
12,885
-2,664
-17% -$482K
BIO icon
220
Bio-Rad Laboratories Class A
BIO
$8.47B
$2.57M 0.05%
3,399
-482
-12% -$361K
A icon
221
Agilent Technologies
A
$38.9B
$2.56M 0.05%
16,059
-199
-1% -$31K
VNQ icon
222
Vanguard Real Estate ETF
VNQ
$39.8B
$2.54M 0.05%
21,864
+6,551
+43% +$715K
NSTG
223
DELISTED
NanoString Technologies, Inc.
NSTG
$2.46M 0.05%
58,209
+13,308
+30% +$582K
VAW icon
224
Vanguard Materials ETF
VAW
$3.01B
$2.37M 0.05%
+12,017
New +$2.26M
VPU
225
Vanguard Utilities ETF
VPU
$8.72B
$2.32M 0.05%
+14,840
New +$2.19M

Similar funds

Exchange Traded Concepts's Q4 2021 Portfolio in Review

As of Q4 2021, Exchange Traded Concepts held 1,276 positions worth $5.16B, up 32% from $3.92B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Exchange Traded Concepts deployed $1.15B of net new capital in Q4 2021, opening 184 new positions and adding to 652 existing holdings. Its largest new stake was Invesco NASDAQ 100 ETF: 3,013,323 shares worth $493M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Vanguard Long-Term Bond ETF, an estimated $152M trimmed.

  • Exchange Traded Concepts's largest Q4 2021 buy was Invesco NASDAQ 100 ETF: 3,013,323 shares worth $493M.
  • Exchange Traded Concepts added most to Vanguard Information Technology ETF in Q4 2021, an estimated $313M increase.
  • Exchange Traded Concepts's biggest Q4 2021 reduction was Vanguard Long-Term Bond ETF, cutting an estimated $152M.
  • Exchange Traded Concepts fully exited Invesco QQQ Trust in Q4 2021, selling an estimated $342M.
  • Exchange Traded Concepts's ten largest holdings make up 42% of its $5.16B portfolio in Q4 2021.
  • Exchange Traded Concepts opened 184 new positions and closed 104 in Q4 2021.
  • Exchange Traded Concepts's portfolio value rose 32% quarter-over-quarter to $5.16B.

Based on Exchange Traded Concepts's 13F filing for Q4 2021, filed 13 Jan 2022.